Cardio-TriTest vs Study Watch with Irregular Pulse Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Cardio-TriTest
by Cardio-Phoenix Inc.
VS
Study Watch with Irregular Pulse Monitor
by Verily Life Sciences

AI Verdict

Cardio-TriTest is a comprehensive diagnostic device for broad cardiovascular disease detection in primary care, utilizing multiple synchronized bio-signals. In contrast, the Verily Study Watch focuses on continuous, single-channel ECG monitoring and irregular pulse detection, primarily for atrial fibrillation and clinical research. While both are cardiology AI tools, Cardio-TriTest offers a more in-depth, multi-modal diagnostic assessment, whereas the Study Watch is geared towards long-term, remote monitoring for specific conditions.

Choose Cardio-TriTest if…

Choose Cardio-TriTest if you require a comprehensive, in-clinic cardiovascular assessment that combines and synchronizes multiple bio-signals (ECG, PCG, and MCG) for a more thorough and earlier detection of various heart conditions. This device is ideal for primary care settings where a detailed, non-invasive diagnostic tool is needed to visually correlate heart activity and aid in physician interpretation.

View Cardio-TriTest →

Choose Study Watch with Irregular Pulse Monitor if…

Choose the Verily Study Watch with Irregular Pulse Monitor if you need a prescription-only, wearable device for continuous, long-term monitoring of adult patients (22+) susceptible to or diagnosed with atrial fibrillation, particularly within clinical research or professional healthcare settings. This watch excels at detecting irregular pulses and recording single-channel ECG rhythms, making it suitable for ongoing patient management and data collection in a free-living environment.

View Study Watch with Irregular Pulse Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cardio-TriTest Study Watch with Irregular Pulse Monitor
Pricing Contact for pricing Contact for pricing
Deployment Clinical setting (device-based) Device-based (wrist-worn watch)
FDA Status 1 AI-estimated True AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Study Watch with Irregular Pulse Monitor

Tool B, the Verily Study Watch, is a wrist-worn device, making it inherently more convenient and less intrusive for continuous monitoring compared to Tool A, the Cardio-TriTest, which is a device-based system used in a clinical setting. The Study Watch's design for daily wear and ease of use for patients, including prompts for ECG acquisition, suggests a higher degree of usability for long-term monitoring and patient engagement.

Clinical Value

Cardio-TriTest

Tool A, Cardio-TriTest, offers a 3-in-1 diagnostic approach combining ECG, PCG, and MCG, providing a more comprehensive assessment of cardiovascular health by synchronizing and visually correlating multiple bio-signals. This multi-modal data acquisition can lead to earlier and more complete detection of cardiovascular diseases compared to Tool B's single-channel ECG and irregular pulse monitoring.

Pricing & Value

Tie

Both tools state 'contact for pricing,' indicating a lack of transparent, publicly available pricing information. Without specific cost details or published economic value studies for either device, it is not possible to determine which offers better pricing or overall value.

Enterprise Readiness

Study Watch with Irregular Pulse Monitor

The Verily Study Watch has been extensively used in large-scale clinical research programs and partnerships with pharmaceutical companies, demonstrating its capability for integration into broader healthcare and research ecosystems. Its focus on continuous data capture and configurable firmware also suggests strong adaptability for enterprise-level deployments and diverse research needs.

Innovation

Cardio-TriTest

Cardio-TriTest's unique combination of three distinct heart bio-signals (ECG, PCG, and MCG) into a single synchronized and visually correlated diagnostic device represents a novel approach to cardiovascular disease detection. This integrated multi-modal sensing and AI-powered analysis for comprehensive heart disease detection offers a more innovative diagnostic method than Tool B's more focused, albeit valuable, irregular pulse monitoring.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details regarding the level of customer support, training, or documentation available for either Cardio-TriTest or the Verily Study Watch. Therefore, it is not possible to determine a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cardio-TriTest Study Watch with Irregular Pulse Monitor
Tool Name Cardio-TriTest Study Watch with Irregular Pulse Monitor
Company Cardio-Phoenix Inc. Verily Life Sciences
Description AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG to synchronize and visually correlate heart bio-signals for earlier and more comprehensive cardiovascular disease detection in primary care. FDA-cleared, prescription-only wearable device designed for adult patients (22+) to monitor and record single-channel ECG rhythms and detect irregular pulses indicative of atrial fibrillation, primarily for use in clinical research and professional healthcare settings.
Key Features 3-in-1 diagnostic device (ECG, PCG, MCG), 12-Lead Electrocardiograph (ECG), 4 Lead Phonocardiograph (PCG), 4 Lead Mechanocardiograph (MCG), Synchronized bio-signal acquisition, Visual correlation of heart bio-signals, AI-powered analysis for heart disease detection, Non-invasive test procedure Single-channel ECG recording, storage, transfer, and display, Irregular pulse monitoring and notification (e.g., for Atrial Fibrillation), Recommendation for ECG acquisition upon irregular pulse detection, Built-in biometric, environmental, and movement sensors, Continuous data capture with long battery life (e.g., 3-day for related Numetric Watch), Designed for clinical research and investigational use, Easy-to-use interface and configurable firmware, Supports multiple languages
Categories Cardiology AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Cardio-TriTest and Study Watch with Irregular Pulse Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cardio-TriTest is designed for primary care settings as a non-invasive, 3-in-1 diagnostic device that combines ECG, PCG, and MCG bio-signals for earlier and more comprehensive cardiovascular disease detection. The Verily Study Watch, a prescription-only wearable, is primarily intended for continuous monitoring and recording of single-channel ECG rhythms to detect irregular pulses indicative of atrial fibrillation, particularly for use in clinical research and professional healthcare settings.
Cardio-TriTest uses AI for heart disease detection through synchronized bio-signal acquisition and visual correlation of ECG, PCG, and MCG. The Verily Study Watch has demonstrated high accuracy in identifying atrial fibrillation, with a sensitivity of 96.1% and specificity of 98.1% for interval-level AF detection in a study comparing it to a 14-day continuous ECG monitor.
Cardio-TriTest is a device-based system for non-invasive testing, which implies a learning curve for its operation and the interpretation of its combined bio-signals. The Verily Study Watch is designed to be easy-to-use with a configurable firmware and an interface that physicians found easy to explain to patients, suggesting a manageable learning curve for its single-channel ECG recording and irregular pulse monitoring functions.
Cardio-TriTest is intended for general practitioners in primary care for a broader and more complete diagnosis of cardiovascular health in adult patients (20 years or older), excluding pediatric and intensive care unit patients. The Verily Study Watch is a prescription-only device for adult patients (22 years or older) with known or suspected heart conditions, particularly for monitoring irregular pulses indicative of atrial fibrillation, and has been extensively used in clinical research for conditions like Parkinson's disease and heart failure.
The provided information does not explicitly detail audit-trail features for either Cardio-TriTest or the Verily Study Watch. Further inquiry with the respective companies would be needed to understand their specific audit capabilities.
Cardio-TriTest is a device-based system for use in a clinical setting, suggesting that multi-site rollout would involve deploying physical devices and training staff at each location. The Verily Study Watch, being a wearable device designed for continuous data capture and cloud-based processing, could facilitate multi-site rollouts by enabling remote monitoring and data collection across various locations, as demonstrated by its use in large observational studies.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cardio-TriTest or Study Watch with Irregular Pulse Monitor

Backers

Who funded each tool's parent company.

Study Watch with Irregular Pulse Monitor

AI Tool Finder
AI-powered search. Results may not be comprehensive.